Connor, Clark & Lunn Investment Management (CC&L)
ATYR

Connor, Clark & Lunn Investment Management (CC&L)’s aTyr Pharma ATYR Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ATYR Stock Details ATYR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$15.1K Buy
2018
Q2 		– Sell
2018
Q1 		$117K Hold
2017
Q4 		$154K Hold
2017
Q3 		$223K Hold
2017
Q2 		$152K Buy
2017
Q1 		$151K Buy
2016
Q4 		$82K Buy
2016
Q3 		$113K Buy
2016
Q2 		$33K Buy